CLINICAL_TRIALS
research
· 2026-02-12
Clinical Trial Update: Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes [Phase 1, Phase 2]
Summary
This clinical trial update notes that a Phase 1/2 study of arginine hydrochloride for managing diabetic ketoacidosis in type 2 diabetes is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: David K Carroll | Conditions: Diabetes (DM), Diabetic Ketoacidosis | Phase 1, Phase 2 | Status: RECRUITING